11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

Clinical trial NCT06100367 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06100367
Sponsor: Changi General Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Aldosteronism Due to Aldosterone Producing Adenoma Primary Aldosteronism Adrenal Tumors

Start date: 2019-12-30
Primary completion: 2025-05-25
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.